BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05984602-completion@plaintrial.com
DTSTAMP:20261023T005621Z
DTSTART;VALUE=DATE:20260101
SUMMARY:A Phase IB Study to Determine the Safety and Tolerability of Canaki
 numab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine 
 in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer — estim
 ated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT05984602
URL:https://plaintrial.com/trial/NCT05984602
END:VEVENT
END:VCALENDAR